These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3593629)

  • 21. [Sublingual nifedipine in hypertension].
    Ratner D; Shoshani E; Chaseeboon K
    Harefuah; 1983 Jan; 104(2):54-5. PubMed ID: 6873758
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic and pharmacodynamic comparisons of oral and sublingual nifedipine in hypertensive Mexican patients.
    Palma-Aguirre JA; Roa-Mendieta A; Hernández-Jiménez LM; Girard-Cuesy ME; León-Urrea F; Alfaro-Mejía A; Frati A; Barreiro-Perera O
    Proc West Pharmacol Soc; 1993; 36():137-41. PubMed ID: 8378367
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of the calcium antagonist nifedipine on intraocular pressure in normal subjects.
    Kelly SP; Walley TJ
    Br J Ophthalmol; 1988 Mar; 72(3):216-8. PubMed ID: 3355809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine.
    Wells DG; Davies GG; Rosewarne F
    Anaesth Intensive Care; 1989 Feb; 17(1):31-3. PubMed ID: 2712272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radionuclide monitoring of left ventricular function after sublingual nifedipine administration at rest and during moderate physical activity.
    Ferro A; Salvatore M; Cuocolo A
    J Nucl Cardiol; 2001; 8(6):669-76. PubMed ID: 11725263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal administration of perforated nifedipine capsules to maintain an effective level of longer duration.
    Ishikawa M; Yokota N; Sawazaki A; Kashiro S; Hirata S; Okada M; Ishikawa K
    Am Heart J; 1986 Nov; 112(5):1116-9. PubMed ID: 3776815
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sublingual captopril versus nifedipine in the treatment of hypertensive crisis].
    Pérez C; Dougnac A; Alvarez M; Andresen M; Díaz O; Geni R; Prat G; Vásquez M
    Rev Med Chil; 1991 Apr; 119(4):402-5. PubMed ID: 1842983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of haemodialysis on the pharmacokinetics and haemodynamic effects of nifedipine during continuous intravenous infusion.
    Kleinbloesem CH; van Brummelen P; Woittiez AJ; Faber H; Breimer DD
    Clin Pharmacokinet; 1986; 11(4):316-22. PubMed ID: 3757391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Inappropriate" physician habits in prescribing oral nifedipine capsules in hospitalized patients.
    Rehman F; Mansoor GA; White WB
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):1035-9. PubMed ID: 8896658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sublingual administration of nifedipine on arterial pressure, plasma renin activity, and glomerular filtration rate in essential hypertension.
    Yurtkuran M; Dilek K; Güllülü M; Yavuz M; Müftüglu A
    Angiology; 1989 Sep; 40(9):791-4. PubMed ID: 2669563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of nifedipine on serum endothelin-1 levels in essential hypertension.
    Akpolat T; Başkol M; Adam B; Arik N; Bedir A
    Clin Nephrol; 1997 Feb; 47(2):130-1. PubMed ID: 9049464
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial.
    Angeli P; Chiesa M; Caregaro L; Merkel C; Sacerdoti D; Rondana M; Gatta A
    Arch Intern Med; 1991 Apr; 151(4):678-82. PubMed ID: 2012448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
    Meyer FP; Banditt P
    Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 35. Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study.
    Sechi LA; Tedde R; Cassisa L; Pala A; Orecchioni C; Uneddu F; Melis A
    Clin Ther; 1989; 11(6):834-40. PubMed ID: 2692825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of nifedipine in human plasma and its use in bioequivalence study.
    Guo Y; Dai J; Qian G; Guo N; Ma Z; Guo X
    Int J Pharm; 2007 Aug; 341(1-2):91-6. PubMed ID: 17507190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
    Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
    Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual nifedipine in hypertensive emergencies with special reference to cerebrovascular accident.
    Gambhir IS; Gupta SS; Singh DS
    J Indian Med Assoc; 1991 Aug; 89(8):231-4. PubMed ID: 1748801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual nifedipine controversy in drug delivery.
    Schumann D
    Dimens Crit Care Nurs; 1991; 10(6):314-20. PubMed ID: 1935527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.